On 2/29/24, Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) stock suffered a major decline of -14.9%, closing at $46.57. Moreover, this decline was accompanied by exceptionally high trading volume at 369% of normal. Relative to the market the stock has been strong over the last nine months but has declined -9.1% during the last week.
Current PriceTarget Research Rating
AMPH’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Amphastar Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Amphastar Pharmaceuticals has a neutral Appreciation Score of 43 and a slightly positive Power Rating of 64, triggering the Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment